Navigation Links
Micromet To Present at the ROTH 21st Annual Orange County Growth Stock Conference
Date:2/13/2009

in a phase 1 clinical trial for the treatment of patients with solid tumors. The Company's third clinical stage antibody is adecatumumab, also known as MT201, a traditional human monoclonal antibody that targets EpCAM-expressing solid tumors. Micromet is developing adecatumumab in collaboration with Merck Serono in a phase 1b clinical trial evaluating adecatumumab in combination with docetaxel for the treatment of patients with metastatic breast cancer. Micromet licensed a fourth clinical stage antibody, MT293, to TRACON Pharmaceuticals, Inc. MT293 is being developed in a phase 1 clinical trial for the treatment of patients with cancer. The Company's preclinical programs include MT203 being developed in collaboration with Nycomed. MT203 is a traditional human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, psoriasis, or multiple sclerosis. Micromet has granted an exclusive option to Bayer Schering Pharma AG to license a BiTE antibody against an undisclosed solid tumor target. Additional BiTE antibodies, targeting CEA, CD33, Her2, EGFR and MCSP, respectively, are in different stages of preclinical development.

Forward-Looking Statements

This release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. These forward-looking statements include statements regarding the efficacy, safety and intended utilization of our product candidates, the development of our BiTE antibody technology, the conduct, timing and results of future clinical trials, expectations of the future expansion of our product pipeline and collaborations, and our plans regarding future presentations of clinical d
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Presented at American Society of Hematology Annual Meeting
2. Micromet to Present at the Piper Jaffray 20th Annual Health Care Conference
3. Micromet, Inc. Reports Second Quarter 2008 Financial Results
4. Micromet, Inc. Reports First Quarter 2008 Financial Results
5. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
6. Micromets BiTE(R) Antibodies Reveal Unique Mode of Action
7. Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 (MEDI-538) in Patients with Acute Lymphoblastic Leukemia
8. Regado Biosciences to Present at the 2009 Wharton Healthcare Business Conference
9. Social Security Disability Applicants Increase Chances for Benefits with Representation
10. NeoGenomics to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
11. Hill-Rom to Present at the Canaccord Adams Musculoskeletal Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Leading nutritional supplement provider Metabolic Nutrition ... and Arnold Fitness EXPO in Columbus, Ohio ... a display booth featuring free samples of its superior ... class-leading fat burner Synedrex. The company will also be ... its top-of-the-line supplements and miniature action figures of its ...
(Date:3/5/2015)... 2015 Think it’s tough to get kids ... get them to brush their teeth. That’s a finding from ... by Delta Dental(1) in conjunction with National Parenting Month in ... getting kids to brush their teeth is one of the ... slightly higher than getting children to eat vegetables regularly (42 ...
(Date:3/5/2015)... 05, 2015 The recent influx of ... promises is alarming, with more and more internet ads ... actual prescription, making it easy for more people to ... their money and endanger their health. The company urges ... prescription online diet pills: , 1.    Where are the products ...
(Date:3/5/2015)... The MTC 5-day Fundamental Implantology Course has been ... variety of dental disciplines, to offer implant placement treatment ... onset we wanted this course to be a truly ... excellence of the lecturers and the sheer energy and ... satisfied our aims." , Unlike large-scale training operations, ...
(Date:3/5/2015)... 05, 2015 Hope For The Warriors® is ... Shoot to be held at Beretta Shooting Grounds (Dover Furnace) ... proceeds from the event will benefit Hope For The Warriors®, ... restoring the family unit, and restoring hope for our service ... our nation’s heroes through a day of clay shooting at ...
Breaking Medicine News(10 mins):Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 2Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 3Health News:Diet Doc Announces Four Simple Questions that Dieters Must Ask Prior to Purchasing Online Diet Pills 2Health News:Diet Doc Announces Four Simple Questions that Dieters Must Ask Prior to Purchasing Online Diet Pills 3Health News:MIS Global Training Center (MTC) Launches its Fundamental Implantology Course for Doctors - with a Difference 2Health News:Hope For The Warriors Announces New York Clay Shoot to Benefit Military Families 2
... Researchers have been able to identify neural signatures ... record, measure and analyze both behavior and ... ,Researchers used a specially designed dual-electroencephalogram (EEG) and ... in this study, The Phi Complex as a ...
... to become one of the first major universities in the ... campus. University officials intend to give the Fayetteville campus ... to the policy: the ban is scheduled to go into ... health issue, said Mary Alice Serafini, assistant vice chancellor for ...
... the Ontario Cancer Institute at Princess Margaret Hospital have successfully ... new cancer drug that is triggered by a laser ... ,In a study published today in the Proceedings of ... Scientist - Division of Biophysics and Bioimaging, Joey and Toby ...
... (Childrens Hospital Boston) and colleagues have identified the cancer ... of childhood. ,'Identifying the cancer stem ... in ERMS will likely lead to new insights into ... explains Dr. Zon. ,Rhabdomyosarcoma (RMS) is an ...
... Rsearchers at the University of Florida, found that self-confidence ... more over a lifetime. Believing in yourself ... the study found. ,People with high opinions ... salaries in middle age than their less confident counterparts, ...
... Desperate Housewives actress -Terri Hatcher, has a unique way of using ... ,The actress is following the advice of her Pharmacist ... and sour wine in a bathwater. It is well is a ... good after four to five days. ,"When you're alone ...
Cached Medicine News:Health News:New Brain Neuromarker May Shed Light on Autism and Schizophrenia 2Health News:New Brain Neuromarker May Shed Light on Autism and Schizophrenia 3Health News:University of Arkansas to Ban Tobacco from Its Campus 2Health News:University of Arkansas to Ban Tobacco from Its Campus 3Health News:Scientists Activate New Cancer Drug Using Light and Oxygen 2Health News:Pediatric Cancer Stem Cell Identified 2Health News:Teenage Self Confidence Can Translate Later into Material Wealth 2Health News:Teenage Self Confidence Can Translate Later into Material Wealth 3
(Date:3/5/2015)... LUNGevity Foundation, the nation,s leading lung ... (FDA) approval of Bristol Myers Squibb,s new immunotherapy ... add another critical new treatment option to fight ... patient,s own immune system to fight cancerous cells. ... patients with squamous cell lung cancer, a population ...
(Date:3/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/gl7m98/japan_pharma ) has ... 2015: Year to Watch out for Authorized Generics (AGs), ... offering. The new pricing system adopted ... (Annexure 1) is a game changer initiative. It pains ... The most of the companies are revalidating their domestic ...
(Date:3/5/2015)... , Mar. 05, 2015 Research and Markets ... of the "Global Rising Stars Outlook 2015" ... for treating diseases are being sought after with fresh ... discovered. One field which is poised to bring a ... the next decades is the Stem cell therapy/Regenerative Medicine ...
Breaking Medicine Technology:LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3Global Pharma Rising Stars Outlook 2015 2
... SAN FRANCISCO , April 21, 2010 ... announced an agreement,with 100X Imaging, Inc. (100X Imaging) to develop and ... exclusive,rights to develop and market products based on this image indexing ... ...
... March 23 The innovative therapies for lung failure from medical device company Novalung GmbH continue to gain acceptance.  Additional financing will allow the Talheim ( Germany ) based ... ... ... ...
Cached Medicine Technology:Strand to Develop and Market Breakthrough Software Solutions to Manage Insights Associated With Microscopy Images 2Novalung Records 50% Growth 2Novalung Records 50% Growth 3
... (Nidek Advanced Vision Information System) is an ... software on a platform designed to communicate ... The network can be expanded in various ... to Nidek products but also to fundus ...
... OcuLight family of infrared laser photocoagulators includes ... These diode lasers serve as a single ... applications, require no regular maintenance or special ... compact design. The OcuLight SLx is now ...
The simplest, most accurate Ortho-K lens fitting system ever!...
... gas permeable contact lenses used for corneal ... nearsightedness (myopia). The patient wears the lenses ... wakening. During the day, nearsightedness is corrected ... Quadra RG contact lenses apply slight pressure ...
Medicine Products: